Effect of Melatonin on Pulmonary Hypertension in Full Term Neonates

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 31 days later Oct 1, 2026 → Nov 1, 2026
See other at-risk trials from Ain Shams University

Record History

  1. Primary completion pushed from Oct 1, 2026 to Nov 1, 2026
  2. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of the study 1. To evaluate safety and efficacy of melatonin as an adjuvant therapy to inhaled nitric oxide generated by NO generator in the treatment of pulmonary hypertension in full term neonates. 2. To assess the effect of inhaled nitric oxide and melatonin on cerebral perfusion.
Trial Details
NCT Number NCT07850934
Lead Sponsor Ain Shams University
Conditions
(from sponsor)		 Congenital Peumonia, Persistent Pulmonary Hypertension of Newborn, Congenital Diaphragmatic Hernia
Related terms Hernias, Diaphragmatic, Congenital, Persistent Fetal Circulation Syndrome
Enrollment 52 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov